[161Tb]Tb-PSMA-I&T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [161Tb]Tb-PSMA-I&T, covering 2025-04-06 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T [Phase 1, Phase 2]